Genmab — November 2020

[Darvin]

EL - 17.19 - strange but your link gives an article dated 7 December 2020

[Helge_LarsenPI-redaktør]

Lige nu søger markedsdeltagerne bare til noget som de tror/mener er bedre end det de har. Mange af dem har pharma. Det forlader de måske helt eller delvist i en periode, men vender så tilbage igen.

[Darvin]

but ok - ASH is 5-7 dec

[Helge_LarsenPI-redaktør]

Genmab
@Genmab
·
1 t
#ICYMI – @WHO
recently launched a global strategy to eliminate #cervicalcancer, it outlines three key steps: vaccination, screening and treatment. Learn more about the commitment by 194 countries to eliminate cervical cancer.https://www.who.int/news/item/17-11-2020-a-cervical-cancer-free-future-first-ever-global-commitment-to-eliminate-a-cancer

[E_L]

I am just way ahead of my time @Darvin

[Solsen]

More hacking by you EL

[Solsen]

Find some epco abstracts....

[E_L]

[Bulder]

Her Hutchings orale https://ash.confex.com/ash/2020/webprogram/Paper133820.html

[Bulder]

Der er 6 abs i alt https://ash.confex.com/ash/2020/webprogram/start.html#srch=words|epcoritamab|method|and|pge|1|byDayany|any|bySymposiumany|any|byAudienceany|any

[Bulder]

" in support of outpatient administration" den har vi da ikke hørt før, har vi?

[Bulder]

Den får da ikke for lidt med superlativerne i konklusionen.

[GeorgeBest]

Fedt Bulder - godt hacket;-)

[Bulder]

hexabody-cd38 https://ash.confex.com/ash/2020/webprogram/Paper140313.html

[Solsen]

CRS events were all grade 1/2 in epco

[Solsen]

Mosunetuzumab astract i ældre naive DLBCL pts viser 5/11 ude efter uge 3 grundet progression. Lidt svært at dømme pga alder på pts.

[Solsen]

Odronextamab (REGN1979) viser lavere responses i DLBCL og FL end epco stort set samme pts.

[Bulder]

New York lukker skoler. NBI lukker mørkerødt.

[Bulder]

Fra CNBC: Stocks turned sharply lower after Mayor Bill de Blasio announced New York City’s public schools will move to remote learning only as the city tries to tamp down a growing number of coronavirus cases.

[GeorgeBest]

Phase 3 Study of Epcoritamab for Advanced DLBCL to Open in Europe, Australia https://immuno-oncologynews.com/2020/11/18/phase-3-study-epcoritamab-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-opening/?cn-reloaded=1